MedPath

The effect of Naltrexone on memory deficit induced by Electroconvulsive therapy

Phase 2
Conditions
Condition 1: Depressive Episode. Condition 2: Memory deficit induced by electroconvulsive therapy.
Depressive episode
Registration Number
IRCT2016060628309N1
Lead Sponsor
Vice chancellor for research,Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion criteria : aged 18 to 65 years; major depression or bipolar depression disorder patients based on DSM4 criteria; indicated for ECT

Exclusion criteria: affected by a prominent medical condition; diagnosed with schizophrenia or mania; a history of ECT in the last 6 month; recent opioid use

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Memory deficit. Timepoint: At the day before ECT sessions, two weeks, one month and three months after ECT sessions. Method of measurement: Wechsler memory test.
Secondary Outcome Measures
NameTimeMethod
Depression severity. Timepoint: Before and 3 months after ECT session. Method of measurement: Hamilton Depression Questionair.
© Copyright 2025. All Rights Reserved by MedPath